KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME

G.S.  Starodub; N.V.  Goryainova; T.P.  Perekhrestenko; O.V.  Basova; N.M.  Tretiak; A.I.  Gordiienko

doi:10.32345/USMYJ.2(95)().2016.5-8

Ukrainian Scientific Medical Youth Journal (Apr 2016)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME

G.S. Starodub,
N.V. Goryainova,
T.P. Perekhrestenko,
O.V. Basova,
N.M. Tretiak,
A.I. Gordiienko

Affiliations

G.S. Starodub: State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
N.V. Goryainova: State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
T.P. Perekhrestenko: State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
O.V. Basova: State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
N.M. Tretiak: State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine
A.I. Gordiienko: State Institution “Institute of Haematology and Transfusion of NAMS of Ukraine”, Kiev, Ukraine

DOI: https://doi.org/10.32345/USMYJ.2(95)().2016.5-8
Journal volume & issue: no. 2(95)
pp. 5 – 8

Abstract

Read online

Patients with MDS RAEB II were examined. The decrease in dynamics of intracellular K³-67 protein expression was determined in patients with MDS RAEB II with positive response to chemotherapy, and the increase in proliferative activity of haematopoietic cells of peripheral blood (PB) and bone marrow (BM) was determined in patients with MDS RAEB II in transformation and acute myeloid leukaemia (AML) after MDS.

mds, k³-67, chemotherapy, peripheral blood, bone marrow.

Published in Ukrainian Scientific Medical Youth Journal

ISSN: 2786-6661 (Print); 2786-667X (Online)
Publisher: Bogomolets National Medical University
Country of publisher: Ukraine
LCC subjects: Medicine: Medicine (General); Medicine: Internal medicine
Website: https://mmj.nmuofficial.com/index.php/journal

About the journal

Abstract

Keywords